Today in Drug Research
Drug Research
Janssen Biotech announces FDA approval of Simponi ulcerative colitis therapy
Janssen Biotech has announced the FDA approval of Simponi (golimumab) to treat moderately to severely active ulcerative colitis (UC) in adult patients with corticosteroid dependence or an inadequate response to or failed to tolerate oral aminosalicylates, oral corticosteroids, azathioprine, or 6-mercaptopurine.
Drug Research > Drug Delivery > News
Latest Drug Research News by Sector
Select a sector from the list or browse by sector below:
Drug Delivery
R-Tech begins enrolling patients in Phase I/II severe dry eye study
R-Tech Ueno has begun enrolling patients with severe dry eye in Phase I/II study of recombinant human serum albumin-containing ophthalmic solution (development code: RU-101) in US.
Drug Research > Drug Delivery > News
Drug Research > Drug Delivery > News
FDA approves Oramed IND application for oral insulin capsule
The US Food and Drug Administration (FDA) has cleared Oramed's investigational new drug (IND) application for ORMD-0801, an oral insulin capsule, allowing the company to begin clinical trials of the drug.
Drug Research > Drug Delivery > News
Drug Research > Drug Delivery > News
Drug Discovery & Development
Impax introduces authorized generic of Zomig in US
Impax Laboratories has introduced authorized generic of Zomig (zolmitriptan) tablets and orally disintegrating tablets, 2.5mg and 5mg, in the US.
Drug Research > Drug Discovery & Development > News
Drug Research > Drug Discovery & Development > News
Almac secures BBSRC programme with UCL
UK-based Almac biocatalysis has secured a Biotechnology and Biological Sciences Research Council (BBSRC) programme with University College London (UCL) aimed at metagenomics and novel enzyme discovery.
Drug Research > Drug Discovery & Development > News
Drug Research > Drug Discovery & Development > News